Skip to main content

ACR 2019 - Report from Day 3 (Tuesday)

Here's my summary of key studies presented Tuesday. 

Tofacitinib in Polyarticular JIA

Herpes Zoster Vaccine Update

Shingrix (GSK), the herpes zoster subunit vaccine (a two-shot series), was approved by the FDA in Fall 2018 and is currently approved for use in adults 50 years and older.

Autoinflammatory Diseases at the ACR Annual Meeting

It has been a wonderful year for autoinflammatory diseases at the ACR Annual Meeting.

Muscle Loss and Frailty in Rheumatic Disease

“If exercise could be purchased in a pill, it would be the single most widely prescribed and beneficial medicine in the nation.” —Robert H. Butler, MD, first director of the National Institute on Aging.

Tweets

Dr. John Cush RheumNow

8 months ago

#ACR19 Rheumatology RoundUp - Kavanaughs Picks: 2505 PsA prevention 1366 Self Joint exams 1120 Rheum burnout 1310 OA Hx 565 Enteropathic arthritis Recs 1823 MRE dx of SI 2773 Machine learning 2772 Antiinflammatory diet in RA 1359 Synovial Bx

Janet Pope Janetbirdope

8 months ago

Killed zoster vaccine was safe with no flare of RA and PsA We need to know if response was good. #ACR19 @RheumNow abst2093 https://t.co/xp2Ju5wZWK

Janet Pope Janetbirdope

8 months ago

Tofacitinib works in Polyarticular JIA. Maybe new hope for kids with JIA and benefits of oral medication #ACR #ACR19 #JIA @RheumNow L23.

Janet Pope Janetbirdope

8 months ago

Remission ever or sustained in RA is same on triple DMARDs Therapy bs biological Rx. From Swedish register. ?channeling bias ?differential access? Either way this supports triple therapy use as impt in RA #ACR #ACR19 @RheumNow Abstract 2908 https://t.co/T8fRPr5a2A

Janet Pope Janetbirdope

8 months ago

Infections In out patients are increased as measured by antimicromial scripts with RA and TNFi use comparing popn controls and pre and post RA TNFi use in pan Iceland registry #ACR19 #ACR @RheumNow abstr 2873. Higher than controls pre &even more after TNFi https://t.co/SlkIPP9WsJ

Cassandra Calabrese CCalabreseDO

8 months ago

A new MBDA-based CVD risk score looks promising, for accurately predicting CVD risk in RA pts, abstr#2350 @RheumNow #ACR19

Cassandra Calabrese CCalabreseDO

8 months ago

Continue or stop biologics for RA if pregnant? Abstr# 2292 and 2279 show increase in flares, GC use, if biologics stopped at time of positive pregnancy test @RheumNow #ACR19

Dr. Rachel Tate uptoTate

8 months ago

Icelandic study shows RA pts use more antimicrobials in the 2 yrs prior to TNFi tx and have increased use 2 yrs after tx. https://t.co/GyUdQT2NvD abs#2873 #ACR19 @RheumNow https://t.co/HKU2IOPwcw

Cassandra Calabrese CCalabreseDO

8 months ago

RA patients failing either UPA or adalimumab may benefit from switching to the other therapy abstr#2907 #ACR19 @RheumNow

Janet Pope Janetbirdope

8 months ago

Can paired synovial MCP biopsies in ERA predict damage? Nice study shows Bcell rich biopsy that is perstistent. This may eventually help with Rx and prognosis #ACR19 #ACR @RheumNow abstract 2870 https://t.co/oQTgiTOtEX

×